Mark Janis
Vice President, Corporate Controller (Johnson and Johnson Acquired Ambrx for 2 Billion March 2024) at Ambrx
Based in San Diego, United States
7-day free trial · no credit card
Seniority
Other
Department
Other
Location
San Diego
Industry
Biotechnology Research
Company size
62
Contact information
Reveal Mark's email and phone
Direct contact data is gated. Sign up and reveal. You only pay for verified records.
m•••••••@ambrx.com
Phone
5 credits+1 ••• •••• ••••
You only pay for valid records. Bounced emails and disconnected numbers cost nothing.
Background
About Mark Janis
Expertise in financial reporting, SEC filings, and SOX compliance to enable strategic decision-making and operational efficiency. As Vice President, Corporate Controller, my team supports the organization's growth by ensuring robust financial controls and seamless integration of complex financial systems post-M&A, including the Johnson & Johnson acquisition. With a mission to enhance financial transparency and accountability, the focus is on supporting cross-functional teams in achieving business goals. The collective efforts have driven process improvements and contributed to the successful navigation of corporate transformations, while maintaining a commitment to upholding accounting standards and delivering stakeholder value.
Decision-makers
Other people at Ambrx
- DZOther
Darryl Z. Lheureux
Director, Clinical Science and Medical Affairs · Other
- MBStaff
Mike Bledsoe
Associate Scientist · Research & Development
- KGStaff
Kedar Gc
Senior Scientist · Research & Development
- LMC-Team
Lawson MacArtney
President and Chief Executive Officer · General Business & Management
- TJDirector
Tsotne Javahishvili
Director, Molecular Biology · Research & Development
Build a list of verified contacts at Ambrx
Free for 7 days · 50 credits · no card · only pay for verified records.
Reach more buyers like Mark
250M+ professionals with verified email and phone. You only pay for records that actually verify.
7-day trial · no credit card · cancel anytime